Drugline is a fortnightly electronic drug bulletin for health professionals.
Scroll

Drugline

Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

Cephalosporin-induced Neurotoxicity

Drugline Volume 492

The product information documents of many cephalosporin products have recently been updated to include warnings of neurotoxicity. Cephalosporins are broad-spectrum beta-lactam antibiotics that are commonly used to treat a range of infections. Neurotoxicity has…

Read more

Tebentafusp for Uveal Melanoma

Drugline Volume 491

Tebentafusp is now available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of advanced uveal melanoma. Uveal melanoma is a rare cancer originating from melanocytes in the choroid, iris, or ciliary body of…

Read more
prescription

Subcutaneous Natalizumab on the PBS

Drugline Volume 490

The subcutaneous form of natalizumab is now available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of relapsing-remitting multiple sclerosis. Natalizumab is a monoclonal antibody that binds to α4 integrins on leucocytes. This…

Read more

Melanoma Therapy Added to the PBS

Drugline Volume 489

From 1 February 2024, Opdualag® will be available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of advanced melanoma. Opdualag® is a combination of two immune checkpoint inhibitors, nivolumab and relatlimab. Nivolumab inhibits…

Read more

Expanded PBS Listing for Orkambi®

Drugline Volume 488

The Pharmaceutical Benefits Scheme (PBS) listing for lumacaftor plus ivacaftor (Orkambi®) has recently been expanded to include patients from one year of age. This medicine is indicated for the treatment of cystic fibrosis in…

Read more

Enfortumab Vedotin on the PBS

Drugline Volume 487

Enfortumab vedotin has recently been added to the Pharmaceutical Benefits Scheme (PBS) for the treatment of locally advanced or metastatic urothelial cancer that has progressed despite therapy. Urothelial cancer begins in the urothelial cells,…

Read more
Load More

March 2024

February 2024

January 2024

November 2023

February 2023

September 2022

August 2022

April 2022

February 2022

December 2021

November 2021

October 2021

August 2021

Post-injection Syndrome (Aug. 20 2021)

Alirocumab on the PBS (Aug. 06 2021)

May 2021

April 2021

PBS Changes for Adalimumab (Apr. 30 2021)

Short-course Oxycodone (Apr. 16 2021)

March 2021

January 2021

December 2020

November 2020

October 2020

September 2020

July 2020

May 2020

March 2020

December 2019

November 2019

October 2019

New Warning for Febuxostat (Oct. 18 2019)

Naloxone Nasal Spray (Oct. 04 2019)

April 2019

New High-Strength Insulin (Apr. 18 2019)

Tofacitinib Safety Issue (Apr. 05 2019)

March 2019

February 2019

January 2019

December 2018